Short sleep duration, obstructive sleep apnea, shiftwork, and the risk of adverse cardiovascular events in patients after an acute coronary syndrome

Journal of the American Heart Association

Volumn 6, Issue 10, 2017, Pages

  Barger, Laura K ^a,b,c   Rajaratnam, Shantha M W ^a,b,c   Cannon, Christopher P ^b   Lukas, Mary Ann ^d   Im, KyungAh ^b   Goodrich, Erica L ^b   Czeisler, Charles A ^a,b   O'Donoghue, Michelle L ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MONASH UNIVERSITY   (Australia)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Cardiovascular risk; Night shift; Obstructive sleep apnea; Sleep; Sleep disorders

Indexed keywords

DARAPLADIB; BENZALDEHYDE DERIVATIVE; OXIME; PHOSPHOLIPASE A2 INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHIFT WORKER; SLEEP DISORDERED BREATHING; SLEEP TIME; CHI SQUARE DISTRIBUTION; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; COMPLICATION; DOUBLE BLIND PROCEDURE; KAPLAN MEIER METHOD; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SHIFT SCHEDULE; SLEEP; TIME FACTOR; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; BENZALDEHYDES; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIMES; PHOSPHOLIPASE A2 INHIBITORS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SHIFT WORK SCHEDULE; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS, CIRCADIAN RHYTHM; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 85032194331     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.117.006959     Document Type: Article

References (49)

1. Buxton OM, Cain SW, O'Connor SP, Porter JH, Duffy JF, Wang W, Czeisler CA, Shea SA. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4:129ra143.
2. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009;106:4453-4458.
3. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32:1484-1492.
4. Dong J, Zhang Y, Qin L. Obstructive sleep apnea and cardiovascular risk: metaanalysis of prospective cohort studies. Atherosclerosis. 2013;229:489-495.
5. Centers for Disease Control and Prevention. Short sleep duration among workers-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:281-285.
6. King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS. Short sleep duration and incident coronary artery calcification. JAMA. 2008;300:2859-2866.
7. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:414-420.
8. Grandner MA, Hale L, Moore M, Patel NP. Mortality associated with short sleep duration: the evidence, the possible mechanisms, and the future. Sleep Med Rev. 2010;14:191-203.
9. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33:585-592.
10. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006-1014.
11. Raghuram A, Clay R, Kumbam A, Tereshchenko LG, Khan A. A systematic review of the association between obstructive sleep apnea and ventricular arrhythmias. J Clin Sleep Med. 2014;10:1155-1160.
12. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034-2041.
13. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31:1071-1078.
14. Suwazono Y, Dochi M, Sakata K, Okubo Y, Oishi M, Tanaka K, Kobayashi E, Nogawa K. Shift work is a risk factor for increased blood pressure in Japanese men: a 14-year historical cohort study. Hypertension. Sep 2008;52:581-586.
15. Sakata K, Suwazono Y, Harada H, Okubo Y, Kobayashi E, Nogawa K. The relationship between shift work and the onset of hypertension in male Japanese workers. J Occup Environ Med. 2003;45:1002-1006.
16. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Speizer FE, Hennekens CH. Prospective study of shift work and risk of coronary heart disease in women. Circulation. 1995;92:3178-3182.
17. Kecklund G, Axelsson J. Health consequences of shift work and insufficient sleep. BMJ. 2016;355:i5210.
18. O'Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques using Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. Am Heart J. 2011;162:613-619.e1
19. O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA. 2014;312:1006-1015. Erratum in: JAMA. 2014;312:1473.
20. Jungquist CR, Mund J, Aquilina AT, Klingman K, Pender J, Ochs-Balcom H, van Wijngaarden E, Dickerson SS. Validation of the behavioral risk factor surveillance system sleep questions. J Clin Sleep Med. 2016;12:301-310.
21. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485-491.
22. Senaratna CV, Perret JL, Matheson MC, Lodge CJ, Lowe AJ, Cassim R, Russell MA, Burgess JA, Hamilton GS, Dharmage SC. Validity of the Berlin questionnaire in detecting obstructive sleep apnea: a systematic review and metaanalysis. Sleep Med Rev. 2017. pii: S1087-0792(16)30145-9. DOI: 10.1016/j. smrv.2017.04.001. [Epub ahead of print] Review.
23. Consensus Conference Panel, Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, Dinges DF, Gangwisch J, Grandner MA, Kushida C, Malhotra RK, Martin JL, Patel SR, Quan SF, Tasali E. Joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: methodology and discussion. J Clin Sleep Med. 2015;11:931-952.
24. Cardiovascular diseases. Media Centre Fact Sheet. World Health Organization. Reviewed September 2016. Available at: http://www.who.int/mediace ntre/factsheets/fs317/en/. Accessed August 18, 2017.
25. Heron M. Deaths: Leading Causes for 2010. National Vital Statistics Reports, Volume 62, Number 6, December 20, 2013. U.S. Department Of Health And Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System Hyattsville, MD: National Center for Health Statistics; 2013.
26. Bin YS, Marshall NS, Glozier N. Sleeping at the limits: the changing prevalence of short and long sleep durations in 10 countries. Am J Epidemiol. 2013;177:826-833.
27. Ayas N, White D, Manson J, Stampfer MJ, Speizer FE, Malhotra A, Hu FB. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163:205-209.
28. Patel S, Malhotra A, White D, Gottlieb D, Hu F. Association between reduced sleep and weight gain in women. Am J Epidemiol. 2006;164:947-954.
29. Gottlieb D, Redline S, Nieto F, Baldwin CM, Newman AB, Resnick HE, Punjabi NM. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep. 2006;29:1009-1014.
30. Gangwisch J, Heymsfield S, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47:833-839.
31. Eguchi K, Pickering T, Schwartz J, Hoshide S, Ishikawa J, Ishikawa S, Shimada K, Kario K. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med. 2008;168:2225-2231. Erratum in: Arch Intern Med. 2009;169:154.
32. Yaggi H, Araujo A, McKinlay J. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29:657-661.
33. Patel S, Ayas N, Malhotra M, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB. A prospective study of sleep duration and mortality risk in women. Sleep. 2004;27:440-444.
34. Aurora RN, Kim JS, Crainiceanu C, O'Hearn D, Punjabi NM. Habitual sleep duration and all-cause mortality in a general community sample. Sleep. 2016;39:1903-1909.
35. Rajaratnam SMW, Barger LK, Lockley SW, Shea SA, Wang W, Landrigan CP, O'Brien CS, Qadri S, Sullivan JP, Cade BE, Epstein LJ, White DP, Czeisler CA; Harvard Work Hours, Health and Safety Group. Sleep disorders, health, and safety in police officers. JAMA. 2011;306:2567-2578.
36. Barger LK, Rajaratnam SM, Wang W, O'Brien CS, Sullivan JP, Qadri S, Lockley SW, Czeisler CA; Harvard Work Hours Health and Safety Group. Common sleep disorders increase risk of motor vehicle crashes and adverse health outcomes in firefighters. J Clin Sleep Med. 2015;11:233-240.
37. Sommerfeld A, Althouse AD, Prince J, Atwood CW, Mulukutla SR, Hickey GW. Obstructive sleep apnea is associated with increased readmission in heart failure patients. Clin Cardiol.2017 Jun 6. DOI: 10.1002/clc.22738. [Epub ahead of print]
38. Statistics BoL. Workers on flexible and shift schedules in May 2004. Available at: http://www.bls.gov/news.release/pdf/flex.pdf. Accessed January 12, 2016.
39. Ftouni S, Sletten TL, Barger LK, Lockley SW, Rajaratnam SM. Shift work disorder. In: Barkoukis T, Matheson JK, Ferber R, Doghramji K, eds. Therapy in Sleep Medicine. Amsterdam, The Netherlands: Elsevier; 2011:378-389.
40. Dijk D, Czeisler C. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci. 1995;15:3526-3538.
41. Knutsson A, Akerstedt T, Jonsson B, Orth-Gomer K. Increased risk of ischaemic heart disease in shift workers. Lancet. 1986;2:89-92.
42. Haupt C, Alte D, Dörr M, Robinson DM, Felix SB, John U, Völzke H. The relation of exposure to shift work with atherosclerosis and myocardial infarction in a general population. Atherosclerosis. 2008;1:205-211.
43. Romon M, Nuttens M, Fievet C, Pot P, Bard JM, Furon D, Fruchart JC. Increased triglyceride levels in shift workers. Am J Med. 1992;93:259-262.
44. Knutsson A, Hallquist J, Reuterwall C, Theorell T, Akerstedt T. Shiftwork and myocardial infarction: a case-control study. Occup EnvironMed. 1999;56:46-50.
45. St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, Bhatt DL; American Heart Association Obesity, Behavior Change, Diabetes, and Nutrition Committees of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health: a scientific statement from the American Heart Association. Circulation. 2016;134:e367-e386.
46. Crowley K, Rajaratnam S, Shea S, Epstein LJ, Czeisler CA, Lockley SW; Harvard Work Hours, Health and Safety Group. Evaluation of a single-channel nasal pressure device to assess obstructive sleep apnea risk in laboratory and home environments. J Clin Sleep Med. 2013;9:109-116.
47. Olson R, Crain TL, Bodner TE, King R, Hammer LB, Klein LC, Erickson L, Moen P, Berkman LF, Buxton OM. A workplace intervention improves sleep: results from the randomized controlled Work, Family, and Health Study. Sleep Health. 2015;1:55-65.
48. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, Mediano O, Chen R, Drager LF, Liu Z, Chen G, Du B, McArdle N, Mukherjee S, Tripathi M, Billot L, Li Q, Lorenzi-Filho G, Barbe F, Redline S, Wang J, Arima H, Neal B, White DP, Grunstein RR, Zhong N, Anderson CS; SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919-931.
49. Kim J, Stewart R, Bae K, Kang HJ, Kim SW, Shin IS, Hong YJ, Ahn Y, Jeong MH, Yoon JS. Correlates and escitalopram treatment effects on sleep disturbance in patients with acute coronary syndrome: K-DEPACS and EsDEPACS. Sleep. 2015;38:1105-1111.